đŸ“£ Introducing Tracenable Pro: Unlock Unlimited Data Exports & Disclosures Access.

IPCA Laboratories Ltd

Common Name
IPCA Laboratories
Country
India
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
16,778
Ticker
IPCALAB
Exchange
NATIONAL STOCK EXCHANGE OF INDIA
Description
Ipca Laboratories Ltd. is a prominent Indian pharmaceutical company that develops, manufactures, and markets a vast array of pharmaceutical products and active pharmaceutical ingredients (APIs). Estab...

IPCA Laboratories's Financial Statements Preview

Below are the financial statements of IPCA Laboratories, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Interested in getting early access to our real-time standardized financial datafeed?
Learn More
All figures in millions of INR
2025 as of 2025-03-31
2024 as of 2024-03-31
Assets——
Non-current assets——
Property, plant & equipment
38,504.9a
41,233a
Capital work-in-progress
6,161.7a
3,235.9a
Goodwill on consolidation
828.1a
828.1a
Goodwill on acquisition
77.7a
77.7a
Other intangible assets
1,070.6a
1,233a
Intangible assets under development
56a
193a
Right of use assets
2,184.2a
2,162.1a
Biological assets other than bearer plant
2.6a
1.4a
Investment accounted for using the equity method
1,910a
1,570.2a
Financial assets——
Investments
253.2a
1,465.9a
Loans
323.5a
885.9a
Others
998.9a
859.3a
Deferred tax assets (net)
169.2a
42.3a
Other non-current assets
2,379.5a
1,836a
Total non-current assets
54,920.1a
55,623.8a
Current assets——
Inventories
25,604.2a
24,713.1a
Financial assets——
Investments
7,633.9a
5,584a
Trade receivables
18,738.2a
16,865.1a
Cash and cash equivalents
1,671.7a
2,089.1a
Bank balances other than
1,770.6a
879.3a
Loans
427.6a
94a
Others
385a
767.3a
Current tax assets (net)
0a
0a
Other current assets
3,439.2a
4,363.6a
Total current assets
59,670.4a
55,355.5a
Non current assets classified as held for sale
3,015a
33.5a
Total assets
117,605.5a
111,012.8a
Equity & liabilities——
Equity——
Equity share capital
253.7a
253.7a
Other equity
69,230.8a
63,068.2a
Equity attributable to owners of the holding company
69,484.5a
63,321.9a
Non-controlling interest
14,398.2a
13,948.1a
Total equity
83,882.7a
77,270a
Liabilities——
Non-current liabilities——
Financial liabilities——
Borrowings
5,432.4a
5,804.1a
Lease liability
509a
399.3a
Other financial liabilities
0a
0a
Provisions
963.1a
868.4a
Deferred tax liabilities (net)
2,949.7a
3,104.7a
Other non-current liabilities
6.4a
9.9a
Total non-current liabilities
9,860.6a
10,186.4a
Current liabilities——
Financial liabilities——
Borrowings
7,584.6a
8,070.9a
Lease liability
101.4a
109.3a
Trade payables——
Dues of micro & small enterprises
991.7a
708.4a
Dues of others
7,470a
7,052.4a
Other financial liabilities
3,653.2a
3,516.1a
Provisions
2,691.7a
2,445.6a
Other current liabilities
867.8a
1,222.3a
Current tax liabilities (net)
482.5a
431.4a
Liabilities associated with non current assets held for sale
19.3a
0a
Total current liabilities
23,862.2a
23,556.4a
Total equity and liabilities
117,605.5a
111,012.8a
Download Data

Verified Sources Behind IPCA Laboratories’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore IPCA Laboratories’s data sources below and access millions more through our Disclosure Search.

a. IPCA Laboratories's Annual Report 2025
a. IPCA Laboratories's Annual Report 2025
b. IPCA Laboratories's Financial Report 2024
b. IPCA Laboratories's Financial Report 2024
Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

Tracenable is building real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?